Comments
Loading...

Leap Therapeutics

LPTXNASDAQ
Logo brought to you by Benzinga Data
$2.79
-0.11-3.79%
At close: -
$2.79
0.000.00%
After Hours: 7:34 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$17.50
Lowest Price Target1
$5.50
Consensus Price Target1
$10.40

Leap Therapeutics (NASDAQ:LPTX) Stock, Analyst Ratings, Price Targets, Forecasts

Leap Therapeutics Inc has a consensus price target of $10.4 based on the ratings of 5 analysts. The high is $17.5 issued by Raymond James on November 14, 2023. The low is $5.5 issued by HC Wainwright & Co. on November 15, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Rodman & Renshaw on November 15, 2024, August 13, 2024, and June 28, 2024, respectively. With an average price target of $6.33 between HC Wainwright & Co., HC Wainwright & Co., and Rodman & Renshaw, there's an implied 127.00% upside for Leap Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jun
1
Aug
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Rodman & Renshaw
Baird
Mizuho
Raymond James

1calculated from analyst ratings

Analyst Ratings for Leap Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Leap Therapeutics (LPTX) stock?

A

The latest price target for Leap Therapeutics (NASDAQ:LPTX) was reported by HC Wainwright & Co. on November 15, 2024. The analyst firm set a price target for $5.50 expecting LPTX to rise to within 12 months (a possible 97.13% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Leap Therapeutics (LPTX)?

A

The latest analyst rating for Leap Therapeutics (NASDAQ:LPTX) was provided by HC Wainwright & Co., and Leap Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Leap Therapeutics (LPTX)?

A

There is no last upgrade for Leap Therapeutics

Q

When was the last downgrade for Leap Therapeutics (LPTX)?

A

There is no last downgrade for Leap Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Leap Therapeutics (LPTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Leap Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Leap Therapeutics was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

Q

Is the Analyst Rating Leap Therapeutics (LPTX) correct?

A

While ratings are subjective and will change, the latest Leap Therapeutics (LPTX) rating was a reiterated with a price target of $5.50 to $5.50. The current price Leap Therapeutics (LPTX) is trading at is $2.79, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch